| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director | SVP &Pres., Lilly Oncology
2 companies
Mahony Susan is a SVP &Pres., Lilly Oncology at ELI LILLY & Co with holdings across 2 companies. Recent SEC Form 4 filings include 0 buys and 8 sells.
Estimated insider holdings value: $31.3M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun 10, 2026 | AXSM Axsome Therapeutics, Inc. | Director | Sale+OE | 600 | $241.70 | $145,017.00 | -23.5% | - | - | |
| Apr 16, 2018 | LLY Eli Lilly & Co | SVP &Pres., Lilly Oncology | Sell | 22,544 | $80.09 | $1,805,633.42 | -23.4% | - | - | |
| Dec 4, 2017 | LLY Eli Lilly & Co | SVP &Pres., Lilly Oncology | Sell | 36,585 | $86.18 | $3,152,895.30 | -40.0% | - | - | |
| Dec 16, 2016 | LLY Eli Lilly & Co | SVP &Pres., Lilly Oncology | Sell | 20,242 | $72.65 | $1,470,615.77 | -20.3% | - | - | |
| Jul 28, 2015 | LLY Eli Lilly & Co | SVP &Pres., Lilly Oncology | Sell | 25,000 | $84.96 | $2,124,000.00 | -28.5% | - | - |